Molly B. Kraus, M.D.

Closed for Enrollment

• Genomic Opioid Optimization of Dosing and Selections (GOODS) Study Scottsdale/Phoenix, AZ

  The purpose of this study is to look at the use of pharmacogenomic data in the perioperative period to guide drug therapy in patients undergoing total knee arthroscopy.